We are live on ! Find out more
TBIO

Translate Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 13th of September, 2021.

Back to rankings

52 hedge funds and large institutions have $298M invested in Translate Bio, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 5

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

50% more capital invested

Capital invested by funds: $200M → $298M (+$98.9M)

11% more funds holding

Funds holding: 47 → 52 (+5)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
52
Holders Change
+5
Holders Change %
+10.64%
% of All Funds
1.13%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
11
Increased
25
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$10.4M
2
BlackRock
BlackRock
New York
+$7.54M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.4M
4
Northern Trust
Northern Trust
Illinois
+$1.36M
5
State Street
State Street
Massachusetts
+$1.31M

Top Sellers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
-$3.07M
2
SFM
Sphera Funds Management
Israel
-$2.32M
3
DCM
DAFNA Capital Management
California
-$1.72M
4
Two Sigma Investments
Two Sigma Investments
New York
-$118K
5
ACH
ArrowMark Colorado Holdings
Colorado
-$113K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$69M +$882 +115 +0%
BG
2
Baupost Group
Massachusetts
$63.9M +$84 +11 +0%
AVA
3
Atlas Venture Advisors
Massachusetts
$40M – – –
OFM
4
Omega Fund Management
Massachusetts
$24.8M – – –
BlackRock
5
BlackRock
New York
$20M +$7.54M +983,170 +100%
RI
6
RTW Investments
New York
$13.8M +$10.4M +1,352,970 New
Federated Hermes
7
Federated Hermes
Pennsylvania
$11.5M – – –
RSCM
8
Rock Springs Capital Management
Maryland
$10.3M – – –
Vanguard Group
9
Vanguard Group
Pennsylvania
$8.61M +$3.4M +443,083 +110%
AG
10
Artal Group
Luxembourg
$6.11M – – –
CAM
11
Cormorant Asset Management
Massachusetts
$4.63M -$8 -1 -0%
PA
12
Perceptive Advisors
New York
$4.43M – – –
BCPEM
13
Bain Capital Public Equity Management
Massachusetts
$4.25M – – –
State Street
14
State Street
Massachusetts
$3.19M +$1.31M +171,411 +121%
Northern Trust
15
Northern Trust
Illinois
$2.94M +$1.36M +177,314 +159%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$2.48M +$969K +126,322 +108%
FI
17
Fosun International
China
$1.14M +$318K +41,488 +56%
FCM
18
Farallon Capital Management
California
$1.02M -$3.07M -400,000 -80%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$816K +$400K +52,177 +187%
Charles Schwab
20
Charles Schwab
California
$667K +$359K +46,848 +252%
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$466K +$237K +30,940 +209%
TA
22
Teachers Advisors
New York
$422K +$220K +28,739 +227%
Norges Bank
23
Norges Bank
Norway
$357K – – –
Deutsche Bank
24
Deutsche Bank
Germany
$352K +$201K +26,217 +308%
RhumbLine Advisers
25
RhumbLine Advisers
Massachusetts
$323K +$164K +21,397 +207%
1
2 3

TBIO Hedge Fund Activity: Q1 2019 in Review

52 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q1 2019, worth a combined $298M — up 50% from $200M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new TBIO positions and 6 closed out — a net gain of 5 holders — while 25 added to existing stakes and 5 trimmed.

The largest buyer was RTW Investments, opening a new position worth an estimated $10.4M. The largest seller was Farallon Capital Management, cutting an estimated $3.07M.

  • 52 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q1 2019, up from 47 in Q4 2018.
  • Funds reported $298M of Translate Bio, Inc. Common Stock stock for Q1 2019, up 50% quarter-over-quarter.
  • 11 funds opened new Translate Bio, Inc. Common Stock positions in Q1 2019 and 6 closed out, a net change of +5 holders.
  • The largest Translate Bio, Inc. Common Stock buyer in Q1 2019 was RTW Investments, an estimated $10.4M added.
  • The largest Translate Bio, Inc. Common Stock seller in Q1 2019 was Farallon Capital Management, an estimated $3.07M sold.

Based on aggregated 13F filings for Q1 2019.